EGFR Activation Limits the Response of Liver Cancer to Lenvatinib

By
Justin.choi
-
0
37
The combination of the epidermal growth factor receptor (EGFR) inhibitor gefitinib and lenvatinib displayed potent anti-proliferative effects in vitro in liver cancer cell lines that expressed EGFR.
[Nature]

Sorry, but the selected Zotpress account can't be found.

Abstract